Page last updated: 2024-08-21

ochratoxin a and Intestinal Neoplasms

ochratoxin a has been researched along with Intestinal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Do, KH; Kim, D; Kim, J; Moon, Y; Park, SH	1

Other Studies

1 other study(ies) available for ochratoxin a and Intestinal Neoplasms

Article	Year
Interference with mutagenic aflatoxin B1-induced checkpoints through antagonistic action of ochratoxin A in intestinal cancer cells: a molecular explanation on potential risk of crosstalk between carcinogens. Oncotarget, 2016, Jun-28, Volume: 7, Issue:26 Topics: Aflatoxin B1; Carcinogens; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Separation; Cytochrome P-450 CYP3A; DNA Adducts; DNA Damage; Dose-Response Relationship, Drug; Drug Interactions; Flow Cytometry; Genome; HCT116 Cells; Humans; Intestinal Neoplasms; Mutagens; Ochratoxins; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53	2016

Article

Year

Interference with mutagenic aflatoxin B1-induced checkpoints through antagonistic action of ochratoxin A in intestinal cancer cells: a molecular explanation on potential risk of crosstalk between carcinogens.

Oncotarget, 2016, Jun-28, Volume: 7, Issue:26

Topics: Aflatoxin B1; Carcinogens; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Separation; Cytochrome P-450 CYP3A; DNA Adducts; DNA Damage; Dose-Response Relationship, Drug; Drug Interactions; Flow Cytometry; Genome; HCT116 Cells; Humans; Intestinal Neoplasms; Mutagens; Ochratoxins; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53

2016